Studying immunity to zoonotic diseases in the natural host-keeping it real

Nature Reviews Immunology

Volumn 13, Issue 12, 2013, Pages 851-861

  Bean, Andrew G D ^a   Baker, Michelle L ^a   Stewart, Cameron R ^a   Cowled, Christopher ^a   Deffrasnes, Celine ^a   Wang, Lin Fa ^a,b   Lowenthal, John W ^a,c  

^a CSIRO   (Australia)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR;

AVIAN INFLUENZA; CRIMEAN CONGO HEMORRHAGIC FEVER; DENGUE; DISEASE TRANSMISSION; EBOLA HEMORRHAGIC FEVER; HENDRA VIRUS INFECTION; HEPATITIS B; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFLUENZA A (H5N1); INNATE IMMUNITY; INTERFERON PRODUCTION; JAPANESE ENCEPHALITIS; NATURAL HOST; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RABIES; REVIEW; RNA INTERFERENCE; ROSS RIVER ALPHA VIRUS; SEQUENCE ANALYSIS; SEVERE ACUTE RESPIRATORY SYNDROME; SIGNAL TRANSDUCTION; SWINE INFLUENZA; VIRUS REPLICATION; WEST NILE FEVER; ZOONOSIS;

ANIMALS; DISEASE RESERVOIRS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MODELS, ANIMAL; PHYSIOLOGY, COMPARATIVE; ZOONOSES;

EID: 84888355659     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3551     Document Type: Review

References (78)

1. Taylor, L. H., Latham, S. M. & Woolhouse, M. E. Risk factors for human disease emergence. Phil. Trans. R. Soc. Lond. B 356, 983-989 (2001). (Pubitemid 32696243)
2. Jones, K. E. et al. Global trends in emerging infectious diseases. Nature 451, 990-993 (2008) (Pubitemid 351301726)
3. Legrand, N., Weijer, K. & Spits, H. Experimental models to study development and function of the human immune system in vivo. J. Immunol. 176, 2053-2058 (2006). (Pubitemid 43201649)
4. Cooper, M. D. & Herrin, B. R. How did our complex immune system evolve Nature Rev. Immunol. 10, 2-3 (2010).
5. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997). (Pubitemid 27334820)
6. Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998). (Pubitemid 28099681)
7. Li, J. et al. B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities. Nature Immunol. 7, 1116-1124 (2006). (Pubitemid 44420657)
8. Zhu, C. et al. Origin of immunoglobulin isotype switching. Curr. Biol. 22, 872-880 (2012).
9. Criscitiello, M. F., Saltis, M. & Flajnik, M. F. An evolutionarily mobile antigen receptor variable region gene: doubly rearranging NAR-TcR genes in sharks. Proc. Natl Acad. Sci. USA 103, 5036-5041 (2006).
10. Parra, Z. E. et al. A unique T cell receptor discovered in marsupials. Proc. Natl Acad. Sci. USA 104, 9776-9781 (2007). (Pubitemid 47175343)
11. Parra, Z. E., Ohta, Y., Criscitiello, M. F., Flajnik, M. F. & Miller, R. D. The dynamic TCR: TCR chains in the amphibian Xenopus tropicalis utilize antibody-like V genes. Eur. J. Immunol. 40, 2319-2329 (2010).
12. Hong, X. et al. Sugar-binding proteins from fish: selection of high affinity "lambodies" that recognize biomedically relevant glycans. ACS Chem. Biol. 8, 152-160 (2013).
13. Wang, L. F., Walker, P. J. & Poon, L. L. Mass extinctions, biodiversity and mitochondrial function: are bats 'special' as reservoirs for emerging viruses Curr. Opin. Virol. 1, 649-657 (2011).
14. Seok, J. et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl Acad. Sci. USA 110, 3507-3512 (2013)
15. Suntharalingam, G. et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355, 1018-1028 (2006). (Pubitemid 44343545)
16. Benatar, M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol. Dis. 26, 1-13 (2007). (Pubitemid 46437445)
17. Tameris, M. D. et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381, 1021-1028 (2013).
18. Mestas, J. & Hughes, C. C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731-2738 (2004) (Pubitemid 38263654)
19. Hein, W. R. & Griebel, P. J. A road less travelled: large animal models in immunological research. Nature Rev. Immunol. 3, 79-84 (2003). (Pubitemid 37328702)
20. Le Douarin, N. M. & Dieterlen-Lievre, F. How studies on the avian embryo have opened new avenues in the understanding of development: a view about the neural and hematopoietic systems. Dev. Growth Differ. 55, 1-14 (2013).
21. Chen, C. L., Bucy, R. P. & Cooper, M. D. T cell differentiation in birds. Semin. Immunol. 2, 79-86 (1990).
22. Glick, B., Chang, T. S. & Jaap, G. The bursa of Fabricius and antibody production. Poult. Sci. 35, 224-225 (1956).
23. Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 147, 258-267 (1957).
24. Waters, W. R. et al. Tuberculosis immunity: opportunities from studies with cattle. Clin. Dev. Immunol. 2011, 768542 (2011).
25. Belser, J. A., Katz, J. M. & Tumpey, T. M. The ferret as a model organism to study influenza A virus infection. Dis. Model. Mech. 4, 575-579 (2011).
26. Menne, S. & Cote, P. J. The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. World J. Gastroenterol. 13, 104-124 (2007). (Pubitemid 46165467)
27. Belov, K. Contagious cancer: lessons from the devil and the dog. Bioessays 34, 285-292 (2012).
28. Clark, I. A. The advent of the cytokine storm. Immunol. Cell Biol. 85, 271-273 (2007).A review of the concept of cytokine storm and its potential role in disease pathogenesis. (Pubitemid 46878938)
29. Lee, N. et al. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clin. Infect. Dis. 45, 723-731 (2007). (Pubitemid 47378886)
30. Karpala, A. J. et al. Highly pathogenic (H5N1) avian influenza induces an inflammatory T helper type 1 cytokine response in the chicken. J. Interferon Cytokine Res. 31, 393-400 (2011).
31. Tisoncik, J. R. et al. Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 76, 16-32 (2012).
32. Pantin-Jackwood, M. J. & Swayne, D. E. Pathobiology of Asian highly pathogenic avian influenza H5N1 virus infections in ducks. Avian Dis. 51, 250-259 (2007). (Pubitemid 46671287)
33. Mahalingam, S. et al. Hendra virus: an emerging paramyxovirus in Australia. Lancet Infect. Dis. 12, 799-807 (2012)
34. Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 (2009).
35. Meliopoulos, V. A. et al. Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens. FASEB J. 26, 1372-1386 (2012).
36. Zhang, G. et al. Comparative analysis of bat genomes provides insight into the evolution of flight and immunity. Science 339, 456-460 (2013)
37. Huang, Y. et al. The duck genome and transcriptome provide insight into an avian influenza virus reservoir species. Nature Genet. 45, 776-783 (2013).
38. The Bactrian Camels Genome Sequencing and Analysis Consortium. Genome sequences of wild and domestic bactrian camels. Nature Commun. 3, 1202 (2012).
39. Pontius, J. U. et al. Initial sequence and comparative analysis of the cat genome. Genome Res. 17, 1675-1689 (2007). (Pubitemid 350080943)
40. Luis, A. D. et al. A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special Proc. Biol. Sci. 280, 20122753 (2013).
41. Papenfuss, A. T. et al. The immune gene repertoire of an important viral reservoir, the Australian black flying fox. BMC Genomics 13, 261 (2012).
42. Ferguson, B. J., Mansur, D. S., Peters, N. E., Ren, H. & Smith, G. L. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife 1, e00047 (2012).
43. Baker, M. L., Schountz, T. & Wang, L. F. Antiviral immune responses of bats: a review. Zoonoses Publ. Health 60, 104-116 (2013).
44. Chahroudi, A., Bosinger, S. E., Vanderford, T. H., Paiardini, M. & Silvestri, G. Natural SIV hosts: showing AIDS the door. Science 335, 1188-1193 (2012).
45. Viney, M. E., Riley, E. M. & Buchanan, K. L. Optimal immune responses: immunocompetence revisited. Trends Ecol. Evol. 20, 665-669 (2005). (Pubitemid 41661329)
46. Schountz, T. et al. Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc. Natl Acad. Sci. USA 104, 15496-15501 (2007). (Pubitemid 47502945)
47. Easterbrook, J. D. & Klein, S. L. Immunological mechanisms mediating hantavirus persistence in rodent reservoirs. PLoS Pathog. 4, e1000172 (2008).
48. Itoh, Y. et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460, 1021-1025 (2009).
49. Chowell, G. et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N. Engl. J. Med. 361, 674-679 (2009).
50. Fisman, D. N. et al. Older age and a reduced likelihood of 2009 H1N1 virus infection. N. Engl. J. Med. 361, 2000-2001 (2009).
51. Chen, Y. et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381, 1916-1925 (2013).
52. De Groot, A. S. et al. Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design. Hum. Vaccin. Immunother. 9, 950-956 (2013).
53. World Health Organization. Overview of the emergence and characteristics of the avian influenza A(H7N9) virus. World Health Organization [online], http://www.who.int/influenza/human-animal-interface/influenza-h7n9/ WHO-H7N9-review-31May13.pdf (2013).
54. Perdue, M. L. & Swayne, D. E. Public health risk from avian influenza viruses. Avian Dis. 49, 317-327 (2005). (Pubitemid 41318886)
55. Barber, M. R., Aldridge, J. R. Jr, Webster, R. G. & Magor, K. E. Association of RIG-I with innate immunity of ducks to influenza. Proc. Natl Acad. Sci. USA 107, 5913-5918 (2010).
56. Bedell, V. M. et al. In vivo genome editing using a high-efficiency TALEN system. Nature 491, 114-118 (2012).
57. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
58. Cade, L. et al. Highly efficient generation of heritable zebrafish gene mutations using homo-and heterodimeric TALENs. Nucleic Acids Res. 40, 8001-8010 (2012).
59. Dahlem, T. J. et al. Simple methods for generating and detecting locus-specific mutations induced with TALENs in the zebrafish genome. PLoS Genet. 8, e1002861 (2012).
60. Hwang, W. Y. et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nature Biotech. 31, 227-229 (2013).
61. Carbery, I. D. et al. Targeted genome modification in mice using zinc-finger nucleases. Genetics 186, 451-459 (2010).
62. Mashimo, T. et al. Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases. PLoS ONE 5, e8870 (2010).
63. Carlson, D. F. et al. Efficient TALEN-mediated gene knockout in livestock. Proc. Natl Acad. Sci. USA 109, 17382-17387 (2012).
64. Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. & Fouchier, R. A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814-1820 (2012).
65. Yu, H. et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet 382, 138-145 (2013).
66. Relman, D. A., Hamburg, M. A., Choffnes, E. R. & Mack, A. in Microbial Evolution and Co-Adaptation: A Tribute to the Life and Scientific Legacies of Joshua Lederberg Ch. 5, 193-272 (National Academies Press, 2009).
67. Patz, J. A. et al. Unhealthy landscapes: policy recommendations on land use change and infectious disease emergence. Environ. Health Perspect. 112, 1092-1098 (2004). (Pubitemid 39029165)
68. Pulliam, J. R. et al. Agricultural intensification, priming for persistence and the emergence of Nipah virus: a lethal bat-borne zoonosis. J. R. Soc. Interface 9, 89-101 (2012).
69. Swenson, S. L. et al. Natural cases of 2009 pandemic H1N1 Influenza A virus in pet ferrets. J. Vet. Diagn. Invest. 22, 784-788 (2010).
70. Reperant, L. A., Kuiken, T. & Osterhaus, A. D. Influenza viruses: from birds to humans. Hum. Vaccin Immunother. 8, 7-16 (2012)
71. Tong, S. et al. A distinct lineage of influenza A virus from bats. Proc. Natl Acad. Sci. USA 109, 4269-4274 (2012).
72. Shi, Z. & Hu, Z. A review of studies on animal reservoirs of the SARS coronavirus. Virus Res. 133, 74-87 (2008). (Pubitemid 351374754)
73. Carver, S., Bestall, A., Jardine, A. & Ostfeld, R. S. Influence of hosts on the ecology of arboviral transmission: potential mechanisms influencing dengue, Murray Valley encephalitis, and Ross River virus in Australia. Vector Borne Zoonot. Dis. 9, 51-64 (2009).
74. Clayton, B. A., Wang, L. F. & Marsh, G. A. Henipaviruses: an updated review focusing on the pteropid reservoir and features of transmission. Zoonoses Publ. Health 60, 69-83 (2013).
75. Rupprecht, C. E., Turmelle, A. & Kuzmin, I. V. A perspective on lyssavirus emergence and perpetuation. Curr. Opin. Virol. 1, 662-670 (2011).
76. Hatz, C. F., Kuenzli, E. & Funk, M. Rabies: relevance, prevention, and management in travel medicine. Infect. Dis. Clin. North Am. 26, 739-753 (2012).
77. Kay, B. H., Boyd, A. M., Ryan, P. A. & Hall, R. A. Mosquito feeding patterns and natural infection of vertebrates with Ross River and Barmah Forest viruses in Brisbane, Australia. Am. J. Trop. Med. Hyg. 76, 417-423 (2007). (Pubitemid 351627730)
78. Tong, S. et al. Climate variability, social and environmental factors, and Ross River virus transmission: research development and future research needs. Environ. Health Perspect. 116, 1591-1597 (2008).